Protease inhibitors do not affect antibody responses to pneumococcal vaccination

Indhira De La Rosa, Iona M. Munjal, Maria Rodriguez-Barradas, Xiaoying Yu, Liise-anne Pirofski, Daniel Mendoza

Research output: Contribution to journalArticle


HIV+ subjects on optimal antiretroviral therapy have persistently impaired antibody responses to pneumococcal vaccination. We explored the possibility that this effect may be due to HIV protease inhibitors (PIs). We found that in humans and mice, PIs do not affect antibody production in response to pneumococcal vaccination.

Original languageEnglish (US)
Pages (from-to)524-529
Number of pages6
JournalClinical and Vaccine Immunology
Issue number6
Publication statusPublished - Jun 1 2016


ASJC Scopus subject areas

  • Clinical Biochemistry
  • Immunology
  • Immunology and Allergy
  • Microbiology (medical)

Cite this